Logos Global Management LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Logos Global Management LP held in its portfolio 67 assets valued at $1,654,958,467 (i.e. $1.66B).

The most valuable assets in the portfolio included: REVOLUTION MEDICINES INC ($238.95M), IDEAYA BIOSCIENCES INC ($123.59M), and PRAXIS PRECISION MEDICINES I ($110.53M).

The chart below shows the top 10 valuable assets, and the table below shows the top 67 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in Logos Global Management LP Portfolio
REVOLUTION MEDICINES INC
IDEAYA BIOSCIENCES INC
PRAXIS PRECISION MEDICINES I
OLEMA PHARMACEUTICALS INC
CIDARA THERAPEUTICS INC
ABIVAX SA
ERASCA INC
OCULAR THERAPEUTIX INC
STRUCTURE THERAPEUTICS INC
DISC MEDICINE INC
Logos Global Management LP - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
REVOLUTION MEDICINES INC 3000000 238950000 COM
IDEAYA BIOSCIENCES INC 3575000 123587750 COM
PRAXIS PRECISION MEDICINES I 375000 110527500 COM NEW
OLEMA PHARMACEUTICALS INC 3208875 80221875 COM
CIDARA THERAPEUTICS INC 310000 68475900 COM NEW
ABIVAX SA 400000 53942000 SPONSORED ADS
ERASCA INC 13000000 48360000 COM
OCULAR THERAPEUTIX INC 3500000 42490000 COM
STRUCTURE THERAPEUTICS INC 600000 41730000 SPONSORED ADS
DISC MEDICINE INC 510000 40499100 COM
MAZE THERAPEUTICS INC 950000 39358500 COM
TANGO THERAPEUTICS INC 4200000 37212000 COM
AVIDITY BIOSCIENCES INC 500000 36065000 COM
BIOGEN INC 200000 35198000 COM
IMMUNOVANT INC 1375000 34952500 COM
JAZZ PHARMACEUTICALS PLC 200000 34000000 SHS USD
TERNS PHARMACEUTICALS INC 750000 30300000 COM
VAXCYTE INC 650000 29991000 COM
IMMUNOCORE HLDGS PLC 850000 29503500 ADS
LB PHARMACEUTICALS INC 1200000 26712000 COM SHS
APELLIS PHARMACEUTICALS INC 1000000 25120000 COM
ARCUS BIOSCIENCES INC 1050000 25021500 COM
DYNE THERAPEUTICS INC 1250000 24450000 COM
DESIGN THERAPEUTICS INC 2500000 23450000 COM
MOONLAKE IMMUNOTHERAPEUTICS 1750000 23065000 CLASS A ORD
ACADIA PHARMACEUTICALS INC 850000 22703500 COM
RHYTHM PHARMACEUTICALS INC 190000 20337600 COM
TREVI THERAPEUTICS INC 1550000 19406000 COM
CYTOKINETICS INC 300000 19062000 COM NEW
MIRUM PHARMACEUTICALS INC 225000 17772750 COM
UNIQURE NV 675000 16152750 SHS
NEWAMSTERDAM PHARMA COMPANY 450000 15786000 ORDINARY SHARES
KINIKSA PHARMACEUTICALS INTL 350000 14437500 ORD SHS CL A
SOLENO THERAPEUTICS INC 300000 13890000 COM
JANUX THERAPEUTICS INC 1000000 13800000 COM
MINERVA NEUROSCIENCES INC 3311000 13310220 COM NEW
VERASTEM INC 1700000 13124000 COM NEW
DIANTHUS THERAPEUTICS INC 315000 12981150 COM
AMYLYX PHARMACEUTICALS INC 950000 11476000 COM
KYMERA THERAPEUTICS INC 130000 10115300 COM
CELLDEX THERAPEUTICS INC NEW 350000 9506000 COM NEW
NURIX THERAPEUTICS INC 500000 9485000 COM
IMMATICS N.V 850000 8925000 SHS
CG ONCOLOGY INC 200000 8304000 COM
ARCELLX INC 115000 7498000 COMMON STOCK
CRESCENT BIOPHARMA INC. 600000 7116000 COM
COMPASS THERAPEUTICS INC 1150000 6175500 COM
JADE BIOSCIENCES INC 395000 6094850 COM NEW
TYRA BIOSCIENCES INC 210000 5520900 COM
ENLIVEN THERAPEUTICS INC 340000 5236000 COM
IMMIX BIOPHARMA INC 1000000 5230000 COM
CENTESSA PHARMACEUTICALS PLC 200000 5002000 SPONSORED ADS
NEUROGENE INC 195000 4017000 COM
IBIO INC 2000000 3860000 COM NEW
CORVUS PHARMACEUTICALS INC 500000 3850000 COM
ORIC PHARMACEUTICALS INC 450000 3681000 COM
DAY ONE BIOPHARMACEUTICALS I 300000 2796000 COM
PHARVARIS N V 100000 2775000 COM
UNICYCIVE THERAPEUTICS INC 473563 2732459 COM NEW
FRACTYL HEALTH INC 1100000 2420000 COM
PALATIN TECHNOLOGIES INC 140000 2153200 COM NEW
ACLARIS THERAPEUTICS INC 600000 1806000 COM
VOR BIOPHARMA INC 100000 1308000 COM NEW
MEREO BIOPHARMA GROUP PLC 1850000 770895 SPON ADS
SEPTERNA INC 23548 656518 COM
DBV TECHNOLOGIES S A 25000 479250 SPONSORED ADS
NUVATION BIO INC 66666 22000 *W EXP 02/10/202